glp-1 resistance GLP-1RAs attenuated obesity and reversed leptin partly via activating the microbiome-derived inosine/A2A pathway glp-1_analogs [TUSOM | Pharmwiki]
Description
Our Partnership with OpenLoop Health Weve teamed up with Des Moines-based OpenLoop Health to offer GLP-1 medications and medication management at competitive prices through its platform, AgileTeleHealth
![glp-1 resistance GLP-1RAs attenuated obesity and reversed leptin partly via activating the microbiome-derived inosine/A2A pathway glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Thus, a receptor can continue to transmit signals solely via -arrestins, and ligands can selectively bias signaling toward either G-proteins or -arrestins [62]
![glp-1 resistance GLP-1RAs attenuated obesity and reversed leptin partly via activating the microbiome-derived inosine/A2A pathway glp-1_analogs [TUSOM | Pharmwiki]](https://148086399.cdn6.editmysite.com/uploads/1/4/8/0/148086399/CJSZB73EAD4AZBGYU62QYATF.jpeg?width=2400&optimize=medium)
Today, GLP-1 medications are among the most prescribed treatments for both obesity and type 2 diabetes, used by millions worldwide
Diabetes Care 41(12):25602569
Because doses are so small, changes occur but
![glp-1 resistance GLP-1RAs attenuated obesity and reversed leptin partly via activating the microbiome-derived inosine/A2A pathway glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-024-10192-9/MediaObjects/10555_2024_10192_Fig1_HTML.png)
The compound is based on the active fragment of endogenous GLP-1 with structural modifications that improve stability
![glp-1 resistance GLP-1RAs attenuated obesity and reversed leptin partly via activating the microbiome-derived inosine/A2A pathway glp-1_analogs [TUSOM | Pharmwiki]](https://3989ac5bcbe1edfc864a-0a7f10f87519dba22d2dbc6233a731e5.ssl.cf2.rackcdn.com/mobo/GLP-1-Mechanism-of-action.png)